Field cancerization in oral lichen planus

European Journal of Surgical Oncology

Volumn 33, Issue 3, 2007, Pages 383-389

  Mignogna, M D ^a   Fedele, S ^a,b   Lo Russo, L ^a   Mignogna, C ^a   de Rosa, G ^a   Porter, S R ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Field cancerization; Inflammation; Oral cancer; Oral lichen planus; Precancerous lesions; Prognosis

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; CLOBETASOL; CORTICOSTEROID; ISOTRETINOIN;

ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL ARTICLE; COHORT ANALYSIS; DEATH; DISEASE SEVERITY; DRUG WITHDRAWAL; DYSPLASIA; HEAD AND NECK CANCER; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LICHEN PLANUS; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA;

ADULT; CELL TRANSFORMATION, NEOPLASTIC; COHORT STUDIES; FEMALE; HUMANS; LICHEN PLANUS, ORAL; MALE; MOUTH NEOPLASMS; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 34047170799     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.09.028     Document Type: Article

References (57)

1. Slaughter D.P., Southwick H.W., and Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6 (1953) 963-968
2. Braakhuis B.J., Tabor M.P., Kummer J.A., Leemans C.R., and Brakenhoff R.H. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63 (2003) 1727-1730
3. Ha P.K., and Califano J.A. The molecular biology of mucosal field cancerization of the head and neck. Crit Rev Oral Biol Med 14 (2003) 363-369
4. van Oijen M.G., and Slootweg P.J. Oral field cancerization: carcinogen-induced independent events or micrometastatic deposits?. Cancer Epidemiol Biomarkers Prev 9 (2000) 249-256
5. Partridge M., Pateromichelakis S., Phillips E., Emilion G., and Langdon J. Profiling clonality and progression in multiple premalignant and malignant oral lesions identifies a subgroup of cases with a distinct presentation of squamous cell carcinoma. Clin Cancer Res 7 (2001) 1860-1866
6. Braakhuis B.J., Tabor M.P., Leemans C.R., van der Waal I., Snow G.B., and Brakenhoff R.H. Second primary tumours and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 24 (2002) 198-206
7. Cianfriglia F., Di Gregorio D.A., and Manieri A. Multiple primary tumours in patients with oral squamous cell carcinoma. Oral Oncol 35 (1999) 157-163
8. Erkal H.S., Mendenhall W.M., Amdur R.J., Villaret D.B., and Stringer S.P. Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites. J Clin Oncol 19 (2001) 1358-1362
9. Sudbo J., Kildal W., Johannessen A.C., et al. Gross genomic aberrations in precancers: clinical implications of a long-term follow-up study in oral erythroplakias. J Clin Oncol 20 (2002) 456-462
10. Sudbo J., Lippman S.M., Lee J.J., et al. The influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med 350 (2004) 1405-1413
11. Ogmundsdottir H.M., Hilmarsdottir H., Astvaldsdottir A., Johannsson J.H., and Holbrook W.P. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in Iceland. Eur J Oral Sci 110 (2002) 192-198
12. Epstein J.B., Wan L.S., Gorsky M., and Zhang L. Oral lichen planus: progress in understanding its malignant potential and the implications for clinical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96 (2003) 32-37
13. van der Meij E.H., Schepman K.P., and van der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96 (2003) 164-171
14. Gandolfo S., Richiardi L., Carrozzo M., et al. Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population. Oral Oncol 40 (2004) 77-83
15. Mignogna M.D., Fedele S., Lo Russo L., Lo Muzio L., and Bucci E. Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence?. Oral Oncol 40 (2004) 120-130
16. Rodstrom P.O., Jontell M., Mattsson U., and Holmberg E. Cancer and oral lichen planus in a Swedish population. Oral Oncol 40 (2004) 131-138
17. Hietanen J., Paasonen M.R., Kuhlefelt M., and Malmstrom M. A retrospective study of oral lichen planus patients with concurrent or subsequent development of malignancy. Oral Oncol 35 (1999) 278-282
18. Mignogna M.D., Lo Russo L., Fedele S., Ruoppo E., Califano L., and Lo Muzio L. Clinical behaviour of malignant transforming oral lichen planus. Eur J Surg Oncol 28 (2002) 838-843
19. Weston A.P., Badr A.S., and Hassanein R.S. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 94 (1999) 3413-3419
20. Pohl C., Hombach A., and Kruis W. Chronic inflammatory bowel disease and cancer. Hepatogastroenterology 47 (2000) 57-70
21. Kara M.A., Bergman J.J., and Tytgat G.N. Follow-up for high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc Clin N Am 13 (2003) 513-533
22. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539-545
23. Liotta L.A., and Kohn E.C. The microenvironment of the humour-host interface. Nature 411 (2001) 375-379
24. O'Byrne K.J., and Dalgleish A.G. Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer 85 (2001) 473-483
25. Pupa S.M., Menard S., Forti S., and Tagliabue E. New insights into the role of extracellular matrix during tumour onset and progression. J Cell Physiol 192 (2002) 259-267
26. Lippman S.M., Sudbo J., and Hong W.K. Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol 23 (2005) 346-356
27. Sugerman P.B., Savage N.W., Walsh L.J., et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 13 (2002) 350-365
28. Kramer I.R., Lucas R.B., Pindborg J.J., and Sobin L.H. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 46 (1978) 518-539
29. Pindborg J.J., Reichart P.A., Smith C.J., and van der Waal I. Histological typing of cancer and precancer of the oral mucosa. 2nd ed. (1997), Springer, Berlin, Heidelberg p. 30
30. Fleming I.D., Cooper J.S., Henson D.E., et al. AJCC cancer staging manual. 5th ed. (1997), Lippincott-Raven, Philadelphia p. 29-39
31. Fritz A., Percy C., Jack A., Shanmugaratnam K., Sobin L.H., and Parkin M.D. WHO international classification of diseases for oncology ICD-O. 3rd ed. (2000), WHO, Geneva
32. Martin I.C., Kerawala C.J., and Reed M. The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 (1998) 444-446
33. Onofre M.A., Sposto M.R., and Navarro C.M. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 (2001) 535-540
34. Mignogna M.D., Lo Muzio L., Lo Russo L., Fedele S., Ruoppo E., and Bucci E. Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus: a 5-year experience. Oral Oncol 37 (2001) 262-267
35. Eisenberg E. Oral lichen planus: a benign lesion. J Oral Maxillofac Surg 58 (2000) 1278-1285
36. Krutchkoff D.J., Cutler L., and Laskowski S. Oral lichen planus: the evidence regarding potential malignant transformation. J Oral Pathol 7 (1978) 1-7
37. Krutchkoff D.J., and Eisenberg E. Lichenoid dysplasia: a distinct histopathologic entity. Oral Surg Oral Med Oral Pathol 60 (1985) 308-315
38. van der Meij E.H., and van der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 32 (2003) 507-512
39. Gandolfo S., Carrozzo M., and Pagano M. Oral lichenoid lesions: what are they?. Oral Oncol 40 (2004) 1057-1058
40. Califano J., van der Riet P., Westra W., et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56 (1996) 2488-2492
41. Califano J., Westra W.H., Meininger G., Corio R., Koch W.M., and Sidransky D. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res 6 (2000) 347-352
42. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
43. Sudbo J., Kildal W., Risberg B., Koppang H.S., Danielsen H.E., and Reith A. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 344 (2001) 1270-1278
44. Jang S.J., Chiba I., Hirai A., Hong W.K., and Mao L. Multiple oral squamous epithelial lesions: are they genetically related?. Oncogene 20 (2001) 2235-2242
45. Tabor M.P., Brakenhoff R.H., Ruijter-Schippers H.J., et al. Multiple head and neck tumours frequently originate from a single preneoplastic lesion. Am J Pathol 161 (2002) 1051-1060
46. Balkwill F., and Coussens L.M. Cancer: an inflammatory link. Nature 431 (2004) 405-406
47. Pikarsky E., Porat R.M., Stein I., et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431 (2004) 461-466
48. Mattsson U., Jontell M., and Holmstrup P. Oral lichen planus and malignant transformation: is a recall of patients justified?. Crit Rev Oral Biol Med 13 (2002) 390-396
49. Bergman J.J., and Tytgat G.N. New developments in the endoscopic surveillance of Barrett's oesophagus. Gut 54 (2005) S38-S42
50. Mashimo H., Wagh M.S., and Goyal R.K. Surveillance and screening for Barrett esophagus and adenocarcinoma. J Clin Gastroenterol 39 (2005) S33-S41
51. Mpofu C., Watson A.J., and Rhodes J.M. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2 (2004) CD000279
52. Mignogna M.D., Fedele S., and Lo Russo L. Dysplasia/neoplasia surveillance in oral lichen planus patients: a description of clinical criteria adopted at a single centre and their impact on prognosis. Oral Oncol 42 (2006) 819-824
53. McMahon J., O'Brien C.J., Pathak I., et al. Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer. Br J Oral Maxillofac Surg 41 (2003) 224-231
54. Sutton D.N., Brown J.S., Rogers S.N., Vaughan E.D., and Woolgar J.A. The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 32 (2003) 30-34
55. Zhang L., and Rosin M.P. Loss of heterozygosity: a potential tool in management of oral premalignant lesions?. J Oral Pathol Med 30 (2001) 513-520
56. Jiang W.W., Fujii H., Shirai T., Mega H., and Takagi M. Accumulative increase of loss of heterozygosity from leukoplakia to foci of early cancerization in leukoplakia of the oral cavity. Cancer 92 (2001) 2349-2356
57. Mao L., Lee J.S., Fan Y.H., et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 2 (1996) 682-685